An op-ed by Dr. Sanjay Pimplikar in today’s New York Times (http://www.nytimes.com/2010/07/20/opinion/20pimplikar.html?_r=1&th&emc=th) also warns against early detection when there is no available cure or disease-modifying treatment. He also cautions about the potential financial and emotional burdens of early detection.
When I mention early detection to people, they almost invariably respond, “I wouldn’t want to know”. And yet they would rarely say that about having a chance for early detection of breast cancer or heart disease.
That is because Alzheimer’s remains a diagnosis without hope. We can change that, even before we find a cure.